The Daily Buyout
UndisclosedPrivate equity buyoutHealthcare & Life SciencesCompleted

Samfara buys Danish API maker Chr. Olesen Synthesis in debut deal

European life sciences investor Samfara completed its first investment, acquiring controlled-substance API manufacturer Chr. Olesen Synthesis from Chr. Olesen and Signet Healthcare Partners funds; terms undisclosed.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

Following healthcare M&A?

The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.

Free · Unsubscribe anytime

See what you get →